Features

Synthetic APIs, referring to pharmaceutical fine chemicals (APIs and intermediates), dominate the global API market, accounting for more than 80% of the global API market. How is the market growing, and what are key trends in API demand and global supply?

The FDA gained the input of bio/pharma companies, CDMOs/CMOs, and industry groups on its proposed Quality Metrics Reporting Program, which will gather info from manufacturers and be used by the FDA in its quality surveillance activities. What did the industry have to say?

As we reach the mid-year mark in 2022, what moves from CDMOs have stood out thus far? What M&A, expansions, or other moves should be on the industry’s radar? DCAT Value Chain Insights provides its take.

Global growth is expected to slump to 2.9% in 2022, significantly lower than 4.1% projected in January, according to a World Bank analysis. Concerns of stagflation, an economic situation not seen since the 1970s, looms.

Which products slated to launch in 2022 are pegged as blockbusters (defined as sales of $1 billion or more) by 2026? What products have analysts identified, and what are key recent developments? Are these products remaining on track to live up to the bill?

Cancer medicine spending rose to $185 billion globally in 2021 and is expected to reach more than $300 billion by 2026. Oncology continues to be the largest therapeutic sector in major markets. What do the numbers show?

Low-volume drugs, such as orphan drugs, present challenges in achieving favorable production economics and in managing the projects themselves. A roundtable of CDMOs provides perspectives on those challenges and best practices to resolve them.

The orphan-drug sector is growing twice as fast as the non-orphan drug market and is projected to represent at least 20% of the global market by 2026 with several blockbusters. Which companies and products are leading the charge?

The metaverse is expected to have far-reaching applications in sectors such as healthcare, manufacturing, education/job training, and communications. What is the metaverse exactly, and what technologies and functions are in play?

Oncology continues to be the leading therapeutic sector in the global bio/pharma market on a value basis and in growth rates. What do the numbers show, and what other therapeutic sectors rank high in growth prospects?